MacroGenics Announces Preliminary Clinical Results from MGD013 and MGC018 to be Presented at the ASCO Annual Meeting

    NEXT STORY
    Kiadis Pharma announces that three abstracts related to its K-NK-cell therapy platform have been accepted at the ASCO 2020 Virtual Annual Meeting
    PREV STORY
    PDS Biotechnology Announces Publication at American Society of Clinical Oncology (ASCO) 2020
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Press news Biocartis Group NV: Biocartis Announces Ten Idylla™ Studies to be Published at Virtual AMP (US) Annual Meeting

    author_avatar
    NASDAQ Market News

    American College of Rheumatology Releases First-Ever Rheumatic Disease Report Card

    New Report Examines Access, Affordability and Lifestyle Factors Affecting Rheumatic Disease Care in all ...

    author_avatar
    NASDAQ Market News

    Immunoassay in R&D Market Value to Surpass USD 7,716.6 Million Revenue Mark by 2023 at 8.18 % CAGR, Says Market Research Future

    author_avatar
    NASDAQ Market News